Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial growth factor receptor status in primary and recurrent ovarian cancer.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Apr 2006

Stadlmann Sylvia, Gueth Uwe, Reiser Ulrich, Diener Pierre-Andre, Zeimet Alain Gustave, Wight Edward, Mirlacher Martina, Sauter Guido, Mihatsch Michael J, Singer Gad

Abstract excerpt

Success of epidermal growth factor receptor (EGFR) targeting agents in different cancer types is related to EGFR gene mutations and/or copy number gains. We investigated the EGFR gene status and protein expression by DNA mutational analysis, fluorescence in situ hybridization (FISH), and immunohistochemistry in tumor tissues from 80 patients with primary and corresponding recurrent ovarian serous carcinomas. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystadenocarcinoma, Serous
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Immunohistochemistry

Share to In Situ Hybridization, Fluorescence

Share to Neoplasm Recurrence, Local

Share to Ovarian Neoplasms

Share to Tissue Array Analysis

Source

Identifiers

PMID: 16554736
DOI: 10.1038/modpathol.3800575

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial growth factor receptor status in primary and recurrent ovarian cancer.PMID 16554736Read ↗

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma.Semantic proximity Read ↗

Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patientSemantic proximity Read ↗

Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancersSemantic proximity Read ↗

Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.Semantic proximity Read ↗

EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagusSemantic proximity Read ↗

Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation.Semantic proximity Read ↗

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.Semantic proximity Read ↗

HER-2/<i>neu</i>Oncogene Amplification by Fluorescence In Situ Hybridization in Epithelial Tumors of the OvarySemantic proximity Read ↗

Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.Semantic proximity Read ↗

Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer.Semantic proximity Read ↗

Amplification of Epidermal Growth Factor Receptor Gene and Its Relationship to Survival in Human Gastric CancerSemantic proximity Read ↗

Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.